HRT Financial’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,303
Closed -$1.97M 2820
2025
Q1
$1.97M Buy
16,303
+8,385
+106% +$1.07M 0.01% 817
2024
Q4
$1.02M Sell
7,918
-16,622
-68% -$2.13M 0.01% 1061
2024
Q3
$2.77M Buy
24,540
+21,787
+791% +$2.29M 0.01% 740
2024
Q2
$251K Buy
+2,753
New +$252K ﹤0.01% 1570
2023
Q4
Sell
-10,273
Closed -$778K 2466
2023
Q3
$778K Buy
10,273
+2,057
+25% +$167K 0.01% 1154
2023
Q2
$647K Sell
8,216
-932
-10% -$78.5K 0.01% 1218
2023
Q1
$789K Buy
9,148
+5,865
+179% +$522K 0.01% 1069
2022
Q4
$265K Sell
3,283
-197
-6% -$16.7K ﹤0.01% 1793
2022
Q3
$285K Sell
3,480
-3,189
-48% -$314K ﹤0.01% 2028
2022
Q2
$731K Sell
6,669
-2,917
-30% -$289K 0.01% 1214
2022
Q1
$910K Buy
+9,586
New +$929K 0.01% 1138
2021
Q4
Sell
-15,192
Closed -$1.44M 3357
2021
Q3
$1.44M Buy
15,192
+3,754
+33% +$370K 0.01% 972
2021
Q2
$1.19M Buy
11,438
+3,571
+45% +$366K 0.01% 908
2021
Q1
$807K Buy
7,867
+4,910
+166% +$490K 0.01% 1342
2020
Q4
$256K Sell
2,957
-5,609
-65% -$520K 0.01% 1381
2020
Q3
$774K Sell
8,566
-2,060
-19% -$165K 0.02% 687
2020
Q2
$712K Buy
+10,626
New +$684K 0.02% 649

Other funds holding DORM

HRT Financial's DORM Position: Q2 2025 in Review

HRT Financial sold out of Dorman Products (DORM) in Q2 2025, closing a stake of 16,303 shares — an estimated $1.97M sold.

HRT Financial first reported a position in DORM in Q2 2020 and held it in 17 quarters. The position peaked at $2.77M in Q3 2024. 340 funds tracked by Wall St. Rank hold DORM as of Q2 2025.

  • HRT Financial reported no remaining Dorman Products position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 16,303 Dorman Products shares in Q2 2025, an estimated $1.97M.
  • HRT Financial first reported a position in Dorman Products in Q2 2020 and held it in 17 quarters.
  • HRT Financial's Dorman Products position peaked at $2.77M in Q3 2024.
  • 340 funds tracked by Wall St. Rank held Dorman Products as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.